Cited by 309Bone health and osteoporosis researchBone Metabolism and DiseasesEstrogen and related hormone effects

The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.

Comparison of trabecular bone microarchitecture and remodeling in glucocorticoid-induced and postmenopausal osteoporosis.

Carbonare, L. Dalle, Arlot, M. E., Chavassieux, P. M., Roux, J. P., Portero, N. R., Meunier, P. J.·2001·Journal of Bone and Mineral Research

DOI 10.1359/jbmr.2001.16.1.97

Open this paper in CoChat — free account

Abstract

Long-term treatment with glucocorticoids (GCs) leads to a rapid bone loss and to a greater risk of fractures. To evaluate the specific effects of this treatment on cancellous bone remodeling, structure, and microarchitecture, we compared 22 transiliac biopsy specimens taken in postmenopausal women (65 ± 6 years) receiving GCs (≥7.5 mg/day, for at least 6 months) and 22 biopsy specimens taken in age-matched women with postmenopausal osteoporosis (PMOP), all untreated and having either at least one vertebral fracture or a T score < −2.5 SD. On these biopsy specimens, we measured static and dynamic parameters reflecting trabecular bone formation and resorption. Also, we performed the strut analysis and evaluated the trabecular bone pattern factor (TBPf), Euler number/tissue volume (E/TV), interconnectivity index (ICI), and marrow star volume (MaSV). Glucocorticoid-induced osteoporosis (GIOP), when compared with PMOP, was characterized by lower bone volume (BV/TV), trabecular thickness (Tb.Th), wall thickness (W.Th), osteoid thickness (O.Th), bone formation rate/bone surface (BFR/BS), adjusted mineral apposition rate/bone surface (Aj.AR/BS), and higher ICI and resorption parameters. After adjustment for BV/TV, the W.Th remained significantly lower in GIOP (p < 0.0001). The active formation period [FP(a+)] was not different. Patients with GIOP were divided into two groups: high cumulative dose GCs (HGCs; 23.7 ± 9.7 g) and low cumulative dose GCs (LGCs; 2.7 ± 1.2 g). HGC when compared with LGC was characterized by lower W.Th (p < 0.05), BV/TV (p < 0.001), Tb.Th (p < 0.05), trabecular number (Tb.N; p < 0.05), FP(a+) (p < 0.05), and nodes (p < 0.05), and higher E/TV (p < 0.05), ICI (p < 0.005), and TBPf (p < 0.05). When HGC was compared with PMOP, the results were similar except for the MaSV, which was significantly higher (p < 0.005). In summary, GIOP was characterized by lower formation and higher resorption than in PMOP, already present after LGC. With HGCs, these changes were associated with a more dramatic bone loss caused by a major loss of trabecular connectivity.

Integrity signals

Registry

Crossref · 10.1359/jbmr.2001.16.1.97

Cites

40 of 40 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Bone histomorphometry: Standardization of nomenclature, symbols, and units: Report of the asbmr histomorphometry nomenclature committee
PARFITT, A. M., Drezner, M. K., Glorieux, F. H., Kanis, J. А., Malluche, H. H., Meunier, P. J., Ott, S. M., & Recker, R. R. (1987) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650020617 · Cited by 5,344
Self-citation
Bone Histomorphometry : Standardization of Nomenclature, Symbols, and Units
PARFITT, A. M., Drezner, M. K., Glorieux, F. H., Kanis, J. А., Malluche, H. H., Meunier, P. J., Ott, S. M., & Recker, R. R. (1987) · Journal of Bone and Mineral Research · Cited by 3,258
Self-citation
Relationships between surface, volume, and thickness of iliac trabecular bone in aging and in osteoporosis. Implications for the microanatomic and cellular mechanisms of bone loss.
PARFITT, A. M., Mathews, C. H. E., Villanueva, A. R., Kleerekoper, M., Frame, B., & Rao, D. S. (1983) · Journal of Clinical Investigation · doi:10.1172/jci111096 · Cited by 1,542
The direct examination of three-dimensional bone architecture in vitro by computed tomography
Feldkamp, L. A., Goldstein, S. A., Parfitt, M. A., Jesion, G., & Kleerekoper, M. (1989) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650040103 · Cited by 1,073
Glucocorticoid-Induced Osteoporosis: Pathogenesis and Management
Lukert, B. P., & Raisz, L. G. (1990) · Annals of Internal Medicine · doi:10.7326/0003-4819-112-5-352 · Cited by 1,063
Steroid-Induced Fractures and Bone Loss in Patients with Asthma
Adinoff, A., & Hollister, J. R. (1983) · New England Journal of Medicine · doi:10.1056/nejm198308043090502 · Cited by 662
Trabecular bone pattern factor—a new parameter for simple quantification of bone microarchitecture
Hahn, M. P., Vogel, M., Pompesius-Kempa, M., & Delling, G. (1992) · Bone · doi:10.1016/8756-3282(92)90078-b · Cited by 540
Low-Dose Prednisone Induces Rapid Reversible Axial Bone Loss in Patients with Rheumatoid Arthritis
Laan, R., van Riel, P. L. C. M., van de Putte, L. B. A., van Erning, L. J. T. O., Hof, M. A. V., & Lemmens, J. A. M. (1993) · Annals of Internal Medicine · doi:10.7326/0003-4819-119-10-199311150-00001 · Cited by 410
Cushing's syndrome—killing disease: discriminatory value of signs and symptoms aiding early diagnosis.
ROSS, E. (1982) · The Lancet · doi:10.1016/s0140-6736(82)92749-0 · Cited by 390
New Developments in the Pathogenesis and Treatment of Steroid-Induced Osteoporosis
Manolagas, S. C., & Weinstein, R. S. (1999) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.1999.14.7.1061 · Cited by 382

Flagged first, then by citations

Show all 40 references

Research works printed but not linked: 2

Le, 1992, Computerized quantitative analysis of the interconnectivity of porous biomaterials, Acta Stereol, 11, 267
Gallagher, 1996, Osteoporosis, 1191

Sorted by citations

Items 101–200 of 308

The anabolic effect of PTH on bone is attenuated by simultaneous glucocorticoid treatment
Oxlund, H., Ørtoft, G., Thomsen, J. S., Danielsen, C. C., Ejersted, C., & Andreassen, T. T. (2006) · Bone · doi:10.1016/j.bone.2006.01.142 · Cited by 43
Intermittent administration of teriparatide enhances graft bone healing and accelerates spinal fusion in rats with glucocorticoid-induced osteoporosis
Sugiura, T., Kashii, M., Matsuo, Y., Morimoto, T., Honda, H., Kaito, T., Iwasaki, M., & Yoshikawa, H. (2014) · The Spine Journal · doi:10.1016/j.spinee.2014.08.001 · Cited by 43
Bone Density and Cortical Structure after Pediatric Renal Transplantation
Terpstra, A. M., Kalkwarf, H. J., Justine Shults, A., Zemel, B. S., Wetzsteon, R. J., Foster, B. J., Strife, C. F., Foerster, D. L., & Leonard, M. B. (2012) · Journal of the American Society of Nephrology · doi:10.1681/asn.2011050480 · Cited by 43
Bone mineral density and vertebral fractures in patients with systemic lupus erythematosus: A systematic review and meta-regression
Pinto, C. M., Rojas‐Villarraga, A., Molano‐González, N., Jiménez-Herrera, E. A., Vázquez, M. D. L. L. L., Montiel-Jarquín, Á. J., García‐Carrasco, M., & Cervera, R. (2018) · PLoS ONE · doi:10.1371/journal.pone.0196113 · Cited by 43
Osteopathy in mild adrenal Cushing’s syndrome and Cushing disease
Frara, S., Allora, A., di Filippo, L., Formenti, A. M., Loli, P., Polizzi, E., Tradati, D., Ulivieri, F. M., & Giustina, A. (2021) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2021.101515 · Cited by 45
Inhibition of cortical and cancellous bone formation in glucocorticoid-treated OVX sheep
Schorlemmer, S., Ignatius, A. A., Claes, L., & Augat, P. (2005) · Bone · doi:10.1016/j.bone.2005.05.002 · Cited by 42
Changes in Bone Mineral Density in Postmenopausal Women Treated with Epidural Steroid Injections for Lower Back Pain
Hwang, B. (2012) · Pain Physician · doi:10.36076/ppj.2012/15/229 · Cited by 41
Glucocorticoid-Induced Osteoporosis: Mechanisms and Therapeutic Approach
Devogelaer, J. (2006) · Rheumatic Disease Clinics of North America · doi:10.1016/j.rdc.2006.09.001 · Cited by 41
Effect of Epidural Steroid Injection on Bone Mineral Density and Markers of Bone Turnover in Postmenopausal Women
Al-Shoha, A., Rao, D. S., Schilling, J., Peterson, E. L., & Mandel, S. S. (2012) · Spine · doi:10.1097/brs.0b013e318270280e · Cited by 40
Prevalence of Reduced Bone Mineral Density in Patients with Anti-neutrophil Cytoplasmic Antibody Associated Vasculitis and the Role of Immunosuppressive Therapy: A Cross-Sectional Study
Boomsma, M. M., Stegeman, C. A., Kramer, A. B., Karsijns, M., Piers, D. A., & Tervaert, J.-W. C. (2002) · Osteoporosis International · doi:10.1007/s198-002-8341-z · Cited by 41
Vertebral Fracture and Cortical Bone Changes in Corticosteroid-Induced Osteoporosis
Tsugeno, H., Tsugeno, H., Fujita, T., Goto, B., Sugishita, T., Hosaki, Y., Ashida, K., Mitsunobu, F., Tanizaki, Y., & Shiratori, Y. (2002) · Osteoporosis International · doi:10.1007/s001980200088 · Cited by 40
Risk factors for osteoporosis in female patients with systemic lupus erythematosus
Munno, O. D., Mazzantini, M., Sedie, A. D., Mosca, M., & Bombardieri, S. (2004) · Lupus · doi:10.1191/0961203303lu1097oa · Cited by 40
Bone microarchitecture in males with corticosteroid-induced osteoporosis
Chappard, D., Josselin, N., Rougé‐Maillart, C., Legrand, É., Baslé, M. F., & Audran, M. (2006) · Osteoporosis International · doi:10.1007/s00198-006-0278-8 · Cited by 41
Hypophosphatemia, Severe Bone Pain, Gait Disturbance, and Fatigue Fractures After Iron Substitution in Inflammatory Bowel Disease: A Case Report
Bartko, J., Roschger, P., Zandieh, S., Brehm, A., Zwerina, J., & Klaus Klaushofer, A. (2017) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.3319 · Cited by 38
Implications of combined ovariectomy and glucocorticoid (dexamethasone) treatment on mineral, microarchitectural, biomechanical and matrix properties of rat bone
Govindarajan, P., Khassawna, T. E., Kampschulte, M., Böcker, W., Hürter, B., Dürselen, L., Faulenbach, M., & Heiß, C. (2013) · International Journal of Experimental Pathology · doi:10.1111/iep.12038 · Cited by 38
Minireview: Nuclear Receptor Regulation of Osteoclast and Bone Remodeling
Jin, Z., Li, X., & Wan, Y. (2014) · Molecular Endocrinology · doi:10.1210/me.2014-1316 · Cited by 38
A reversal phase arrest uncoupling the bone formation and resorption contributes to the bone loss in glucocorticoid treated ovariectomised aged sheep
Andreasen, C. M., Ding, M. L., Overgaard, S., Bollen, P. J. A., & Andersen, T. L. (2015) · Bone · doi:10.1016/j.bone.2015.02.014 · Cited by 37
Chronic Ethanol Consumption Induces Osteopenia via Activation of Osteoblast Necroptosis
Guo, M., Huang, Y., Wu, Q., Chai, L., Jiang, Z., Zeng, Y., Wan, S., Tan, X., Long, Y., Gu, J., et al. (2021) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2021/3027954 · Cited by 39
How to prevent glucocorticoid-induced osteoporosis
Dore, R. K. (2010) · Cleveland Clinic Journal of Medicine · doi:10.3949/ccjm.77a.10003 · Cited by 36
Bone formation markers in patients with glucocorticoid-induced osteoporosis treated with teriparatide or alendronate
Eastell, R., Chen, P., Saag, K. G., Burshell, A., Wong, M., Warner, M. R., & Krege, J. H. (2010) · Bone · doi:10.1016/j.bone.2009.12.021 · Cited by 38
Dietary-Induced Metabolic Acidosis Decreases Bone Mineral Density in Mature Ovariectomized Ewes
MacLeay, J. M., Olson, J. D., Enns, R. M., Les, C. M., TOTH, C. A., Wheeler, D. L., & Turner, A. S. (2004) · Calcified Tissue International · doi:10.1007/s00223-004-0217-7 · Cited by 36
Effectiveness of Teriparatide in Postmenopausal Women with Osteoporosis and Glucocorticoid Use: 3-Year Results from the EFOS Study
Karras, D., Stoykov, I., Lems, W. F., Langdahl, B. L., Ljunggren, Ö., Barrett, A., Walsh, J. B., Fahrleitner‐Pammer, A., Rajzbaum, G., Jakob, F. J., et al. (2012) · The Journal of Rheumatology · doi:10.3899/jrheum.110947 · Cited by 35
Antiosteoporotic activity of Du–Zhong–Wan water extract in ovariectomized rats
Li, F., Yang, X., Bi, J., Yang, Z., & Zhang, C.-F. (2016) · Pharmaceutical Biology · doi:10.3109/13880209.2015.1133657 · Cited by 35
Side-to-side and within-side variability of 3D bone microarchitecture by conventional micro-computed tomography of paired iliac crest biopsies
Chappard, C., Marchadier, A., & Benhamou, C. L. (2008) · Bone · doi:10.1016/j.bone.2008.02.019 · Cited by 35
Bone fragility in male glucocorticoid-induced osteoporosis is not defined by bone mineral density
Hayashi, K., Yamamoto, M., Murakawa, Y., Yamauchi, M., Kaji, H., Yamaguchi, T., & Sugimoto, T. (2009) · Osteoporosis International · doi:10.1007/s00198-009-0901-6 · Cited by 35
Trabecular bone microarchitecture is related to the number of risk factors and etiology in osteoporotic men
Legrand, É., Audran, M., Guggenbuhl, P., Levasseur, R., Chalès, G., Baslé, M. F., & Chappard, D. (2007) · Microscopy Research and Technique · doi:10.1002/jemt.20501 · Cited by 35
Glycyrrhizic acid (GCA) as 11β-hydroxysteroid dehydrogenase inhibitor exerts protective effect against glucocorticoid-induced osteoporosis
Ramli, E. S. M., Suhaimi, F., Asri, S. F. M., Ahmad, F., & Soelaiman, I. (2013) · Journal of Bone and Mineral Metabolism · doi:10.1007/s00774-012-0413-x · Cited by 33
Ibandronate increases cortical bone density in patients with systemic lupus erythematosus on long-term glucocorticoid
Li, E. K., ZHU, T. Y., Hung, V., Kwok, A. W. L., Lee, V. W. Y., Lee, K. K., Griffith, J. F., Li, M., Wong, K. C., Leung, P., et al. (2010) · Arthritis Research & Therapy · doi:10.1186/ar3170 · Cited by 35
A Histomorphometric Study of Cortical Bone of the Iliac Crest in Patients Treated with Glucocorticoids
Vedi, S., Elkin, S., & Compston, J. E. (2005) · Calcified Tissue International · doi:10.1007/s00223-004-0205-y · Cited by 33
Low Bone Mineral Density, But Not Epidural Steroid Injection, Is Associated with Fracture in Postmenopausal Women with Low Back Pain
Hwang, B. (2012) · Pain Physician · doi:10.36076/ppj.2012/15/441 · Cited by 32
Balancing benefits and risks of glucocorticoids in rheumatic diseases and other inflammatory joint disorders: new insights from emerging data. An expert consensus paper from the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO)
Cooper, C. C., Bardin, T., Brandi, M. L., Cacoub, P., Caminis, J. N., Civitelli, R., Cutolo, M., Dere, W. H., Devogelaer, J., Díez‐Pérez, A., et al. (2016) · Aging Clinical and Experimental Research · doi:10.1007/s40520-015-0522-1 · Cited by 32
Interpretation of Steroid Biomarkers in 21-Hydroxylase Deficiency and Their Use in Disease Management
Sarafoglou, K., Merke, D. P., Reisch, N., der Grinten, H. L. C., Falhammar, H., & Auchus, R. J. (2023) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgad134 · Cited by 32
Bisphosphonate Use and Risk of Atypical Femoral Fractures: A Danish Case-Cohort Study With Blinded Radiographic Review
Bauer, D. C., Black, D. M., Dell, R., Fan, B., Smith, C., Ernst, M. T., Jurik, A. G., Frøkjær, J. B., Boesen, M., Vittinghoff, E., et al. (2024) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgae023 · Cited by 30
Glucocorticoid-induced osteoporosis
de Gregório, L. H., Lacativa, P. G. S., Melazzi, A. C. C., & Russo, L. A. T. (2006) · Arquivos Brasileiros de Endocrinologia & Metabologia · doi:10.1590/s0004-27302006000400024 · Cited by 30
Recommendations for the registration of agents for prevention and treatment of glucocorticoid-induced osteoporosis: an update from the Group for the Respect of Ethics and Excellence in Science
Compston, J. E., Reid, D. M., Boisdron, J., Brandi, M. L., Burlet, N., Cahall, D. L., Delmas, P. D., Dere, W. H., Devogelaer, J.-P., Fitzpatrick, L. A., et al. (2008) · Osteoporosis International · doi:10.1007/s00198-008-0670-7 · Cited by 30
Glucocorticoid‐treated sheep as a model for osteopenic trabecular bone in biomaterials research
Augat, P., Schorlemmer, S., Gohl, C., Iwabu, S., Ignatius, A. A., & Claes, L. (2003) · Journal of Biomedical Materials Research Part A · doi:10.1002/jbm.a.10601 · Cited by 30
High bone marrow fat in patients with Cushing’s syndrome and vertebral fractures
Ferraù, F., Giovinazzo, S., Messina, E., Tessitore, A., Vinci, S. L., Mazziotti, G., Lania, A. G., Granata, F., & Cannavò, S. (2019) · Endocrine · doi:10.1007/s12020-019-02034-4 · Cited by 30
A novel 11β-HSD1 inhibitor improves diabesity and osteoblast differentiation
Park, J. S., Bae, S. J., Choi, S., Son, Y. H., Park, S. B., Rhee, S. D., Kim, H. Y., Jung, W. H., Kang, S. K., Ahn, J. H., et al. (2014) · Journal of Molecular Endocrinology · doi:10.1530/jme-13-0177 · Cited by 29
Bone Microarchitecture Assessment by High-Resolution Peripheral Quantitative Computed Tomography in Patients with Systemic Lupus Erythematosus Taking Corticosteroids
Li, E. K., ZHU, T. Y., Tam, L., HUNG, V. W., Griffith, J. F., Li, T. K., Li, M., Wong, K. C., Leung, P., Kwok, A. W. L., et al. (2010) · The Journal of Rheumatology · doi:10.3899/jrheum.091231 · Cited by 28
Decreased Trabecular Bone Score in Patients With Active Endogenous Cushing’s Syndrome
Stachowska, B., Halupczok-Żyła, J., Kuliczkowska-Płaksej, J., Syrycka, J., & Bolanowski, M. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.593173 · Cited by 28
Glucocorticoids and the risk of osteoporosis
Caplan, L., & Saag, K. G. (2008) · Expert Opinion on Drug Safety · doi:10.1517/14740330802648194 · Cited by 28
Bone matrix development in steroid-induced osteoporosis is associated with a consistently reduced fibrillar stiffness linked to altered bone mineral quality
Xi, L., Falco, P. D., Barbieri, E., Karunaratne, A., Bentley, L., Esapa, C. T., Terrill, N. J., Brown, S. D. M., Cox, R., Davis, G. R., et al. (2018) · Acta Biomaterialia · doi:10.1016/j.actbio.2018.05.053 · Cited by 28
Evaluation of bone mineral density of the peripheral skeleton in pre‐ and postmenopausal women with newly diagnosed endogenous Cushing's syndrome
Karavitaki, N., Ioannidis, G., Giannakopoulos, F., Mavrokefalos, P., & Thalassinos, N. C. (2004) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2004.01968.x · Cited by 28
Bone fragility: current reviews and clinical features.
Leali, P. T., Doria, C., Zachos, A., Ruggiu, A., Milia, F., & Barca, F. (2009) · PubMed Central · Cited by 27
Prednisolone induces osteocytes apoptosis by promoting Notum expression and inhibiting PI3K/AKT/GSK3β/β-catenin pathway
Li, C., Yang, P., Liu, B., Bu, J., Liu, H., Guo, J., Hasegawa, T., Si, H., & Li, M. (2021) · Journal of Molecular Histology · doi:10.1007/s10735-021-10006-0 · Cited by 27
Drug and Hormone Effects on Vitamin D Metabolism
Emkey, G. R., & Epstein, S. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-809963-6.00075-4 · Cited by 27
Therapeutic effects of radix dipsaci, pyrola herb, and cynomorium songaricum on bone metabolism of ovariectomized rats
Liu, M., Xiao, G. G., Rong, P., Zhang, Z., Dong, J., Zhao, H., Li, H., Li, Y., Pan, J., Liu, H., et al. (2012) · BMC Complementary and Alternative Medicine · doi:10.1186/1472-6882-12-67 · Cited by 27
Slow Rebound of Cancellous Bone After Mainly Steroid-Induced Osteoporosis in Ovariectomized Sheep
Goldhahn, J., Jenet, A., Schneider, E., & Lill, C. A. (2005) · Journal of Orthopaedic Trauma · doi:10.1097/00005131-200501000-00005 · Cited by 26
Effects of micro/nano strontium‐loaded surface implants on osseointegration in ovariectomized sheep
Liu, F., Li, Y., Liang, J., Sui, W., Bellare, A., & Kong, L. (2019) · Clinical Implant Dentistry and Related Research · doi:10.1111/cid.12719 · Cited by 26
Interindividual and intraspecimen variability of 3-D bone microarchitectural parameters in iliac crest biopsies imaged by conventional micro-computed tomography
Chappard, C., Marchadier, A., & Benhamou, L. (2008) · Journal of Bone and Mineral Metabolism · doi:10.1007/s00774-008-0856-2 · Cited by 26
Immunocytochemical Evidence on the Effects of Glucocorticoids on Type I Collagen Synthesis in Human Osteoblastic Cells
Hernández, M. V., Guañabens, N., Álvarez, L., Monegal, A., Peris, P., Riba, J., Ercilla, G., de Osaba, M. J. M., & Muñoz-Gómez, J. (2003) · Calcified Tissue International · doi:10.1007/s00223-002-1095-5 · Cited by 25
Sialoglycoproteins prepared from the eggs of Carassius auratus prevent bone loss by inhibiting the NF-κB pathway in ovariectomized rats
Xia, G., Wang, J., Sun, S., Zhao, Y., Wang, Y., Yu, Z. S., Wang, S., & Xue, C. (2016) · Food & Function · doi:10.1039/c5fo00955c · Cited by 25
Promotion of osteoclast survival and antagonism of bisphosphonate-induced osteoclast apoptosis by glucocorticoids
Weinstein, R. S., Chen, J., Powers, C. C., Stewart, S. A., Landes, R. D., Bellido, T., Jilka, R. L., PARFITT, A. M., & Manolagas, S. C. (2002) · Journal of Clinical Investigation · doi:10.1172/jci200214538 · Cited by 25
Disuse induced by botulinum toxin affects the bone marrow expression profile of bone genes leading to a rapid bone loss.
Libouban, H., Drévo, M. A. L., & Chappard, D. (2013) · PubMed · Cited by 24
Long‐term health consequences of congenital adrenal hyperplasia
Pofi, R., Ji, X., Krone, N. P., & Tomlinson, J. (2023) · Clinical Endocrinology · doi:10.1111/cen.14967 · Cited by 28
Bone metabolism in Langerhans cell histiocytosis
Anastasilakis, A. D., Tsoli, M., Kaltsas, G., & Makras, P. (2018) · Endocrine Connections · doi:10.1530/ec-18-0186 · Cited by 24
Ibandronate treatment reverses glucocorticoid-induced loss of bone mineral density and strength in minipigs
Glüer, C.-C., Scholz-Ahrens, K. E., Helfenstein, A., Delling, G., Timm, W., Açil, Y., Barkmann, R., Hassenpflug, J., Stampa, B., Bauss, F., et al. (2006) · Bone · doi:10.1016/j.bone.2006.10.019 · Cited by 25
Extensive expertise in endocrinology: advances in the management of glucocorticoid-induced osteoporosis
Compston, J. E. (2023) · European Journal of Endocrinology · doi:10.1093/ejendo/lvad029 · Cited by 23
The rs4844880 polymorphism in the promoter region of the HSD11B1 gene associates with bone mineral density in healthy and postmenopausal osteoporotic women
Feldman, K., Szappanos, Á., Butz, H., Grolmusz, V. K., Majnik, J., Likó, I., Kriszt, B., Lakatos, P. L., Tóth, M., Rácz, K., et al. (2012) · Steroids · doi:10.1016/j.steroids.2012.08.014 · Cited by 23
From histology to micro-CT: Measuring and modeling resorption cavities and their relation to bone competence
Vanderoost, J. (2014) · World Journal of Radiology · doi:10.4329/wjr.v6.i9.643 · Cited by 23
Immunolocalization of MMP 2, 9 and 13 in prednisolone induced osteoporosis in mice.
Sun, B., Sun, J., Han, X., Liu, H., Li, J., Du, J., Feng, W., Liu, B., Cui, J., Guo, J., et al. (2016) · PubMed · doi:10.14670/hh-11-702 · Cited by 23
Morphological, histomorphometric, and microstructural alterations in human bone metastasis from breast carcinoma
Vukmirović-Popović, S., Colterjohn, N. R., Lhoták, Š., Duivenvoorden, W., Orr, F. W., & Singh, G. (2002) · Bone · doi:10.1016/s8756-3282(02)00847-5 · Cited by 23
Effects of Alendronate and Strontium Ranelate on Cancellous and Cortical Bone Mass in Glucocorticoid-Treated Adult Rats
Sun, P., Cai, D. H., Li, Q., Chen, H., Deng, W., He, L., & Yang, L. (2010) · Calcified Tissue International · doi:10.1007/s00223-010-9363-2 · Cited by 23
Management of glucocorticoid-induced osteoporosis: prevalence, and emerging treatment options
Payer, J. (2010) · Drug Healthcare and Patient Safety · doi:10.2147/dhps.s7197 · Cited by 22
Intervention Thresholds for Treatment in Patients with Glucocorticoid-Induced Osteoporosis: Systematic Review of Guidelines
Lee, T.-H., Song, Y., Kim, H., Sung, Y., & Cho, S. (2020) · Journal of Bone Metabolism · doi:10.11005/jbm.2020.27.4.247 · Cited by 23
Cushing’s disease and bone
Zdrojowy-Wełna, A., Stachowska, B., & Bolanowski, M. (2024) · Pituitary · doi:10.1007/s11102-024-01427-7 · Cited by 21
High Evening Cortisol Level Is Associated With Low TBS and Increased Prevalent Vertebral Fractures: OsteoLaus Study
Rodríguez, E. G., Lamy, O., Stoll, D., Metzger, M., Preisig, M., Kuehner, C., Vollenweider, P., Marques-Vidal, P. M., Waeber, G., Aubry‐Rozier, B., et al. (2017) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-3804 · Cited by 21
Reduced bone mineral density in adult patients with Langerhans cell histiocytosis
Makras, P., Terpos, E., Kanakis, G., Παπαθεοδώρου, Α., Anastasilakis, A. D., Kokkoris, P., & Kaltsas, G. (2011) · Pediatric Blood & Cancer · doi:10.1002/pbc.23166 · Cited by 21
Adjuvant drug-assisted bone healing: Part I – Modulation of inflammation
Rothe, R., Schulze, S., Neuber, C., Hauser, S., Rammelt, S., & Pietzsch, J. (2019) · Clinical Hemorheology and Microcirculation · doi:10.3233/ch-199102 · Cited by 21
Parathyroid Hormone (1-34) Counteracts the Suppression of Interleukin-11 Expression by Glucocorticoid in Murine Osteoblasts: A Possible Mechanism for Stimulating Osteoblast Differentiation Against Glucocorticoid Excess
Kuriwaka-Kido, R., Kido, S., Miyatani, Y., Ito, Y., Kondo, T., Omatsu, T., Dong, B., Endo, I., Miyamoto, K., & Matsumoto, T. (2013) · Endocrinology · doi:10.1210/en.2013-1915 · Cited by 20
Changes in trabecular bone density in incident pediatric Crohn’s disease: a comparison of imaging methods
Tsampalieros, A. K., Berkenstock, M., Zemel, B. S., Griffin, L. M., Justine Shults, A., Burnham, J. M., Baldassano, R. N., & Leonard, M. B. (2014) · Osteoporosis International · doi:10.1007/s00198-014-2701-x · Cited by 20
3 Tesla MRI detects deterioration in proximal femur microarchitecture and strength in long‐term glucocorticoid users compared with controls
Chang, G. A., Rajapakse, C. S., Regatte, R. R., Babb, J. S., Saxena, A., Belmont, M. H., & Honig, S. (2015) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.24927 · Cited by 21
Bone ultrasonography in glucocorticoid-induced osteoporosis
Cepollaro, C., Gonnelli, S., Rottoli, P., Montagnani, A., Caffarelli, C., Bruni, D., Nikiforakis, N., Fossi, A., Rossi, S., & Nuti, R. (2004) · Osteoporosis International · doi:10.1007/s00198-004-1741-z · Cited by 20
11β-Hydroxysteroid Dehydrogenase, an Amplifier of Glucocorticoid Action in Osteoblasts
CANALIS, E. M., & Delany, A. M. (2002) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2002.17.6.987 · Cited by 20
Phosphatidylserine nanoliposomes inhibit glucocorticoid-induced osteoporosis: A potential combination therapy with alendronate
Eskandarynasab, M., Doustimotlagh, A. H., Takzaree, N., Etemad‐Moghadam, S., Alaeddini, M., Dehpour, A. R., Goudarzi, R., & Partoazar, A. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.118033 · Cited by 19
Histomorphology
Stout, S. D., Cole, M. E., & Agnew, A. M. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-809738-0.00006-5 · Cited by 21
Trabecular Bone Score Is a Useful Parameter for the Prediction of Vertebral Fractures in Patients With Polymyalgia Rheumatica
Kim, H., Lee, H. Y., Jung, J.-Y., Suh, C., Chung, Y., & Choi, Y. J. (2019) · Journal of Clinical Densitometry · doi:10.1016/j.jocd.2019.05.006 · Cited by 19
Bone Alterations in Children and Young Adults With Renal Transplant Assessed by Phalangeal Quantitative Ultrasound
Mussa, A., Porta, F., Gianoglio, B., Gaido, M., Nicolosi, M. G., de Terlizzi, F., Sanctis, C. D., & Coppo, R. (2007) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2007.06.002 · Cited by 19
Use of high-dose intermittent systemic glucocorticoids and the risk of fracture in patients with chronic obstructive pulmonary disease
Oshagbemi, O. A., Burden, A. M., Shudofsky, K. N., Driessen, J. H. M., Vestergaard, P., Krings, A., Franssen, F. M. E., van den Bergh, J. P., & de Vries, F. (2018) · Bone · doi:10.1016/j.bone.2018.02.007 · Cited by 18
Bone densitometry, steroids and osteoporosis
Blake, G. M., & Fogelman, I. (2002) · Current Opinion in Nephrology & Hypertension · doi:10.1097/00041552-200211000-00012 · Cited by 18
Glucocorticoids employ the monomeric glucocorticoid receptor to potentiate vitamin D 3 and parathyroid hormone‐induced osteoclastogenesis
Conaway, H. H., Henning, P., Lie, A., Tuckermann, J. P., & Lerner, U. H. (2019) · The FASEB Journal · doi:10.1096/fj.201802729rrr · Cited by 17
Abnormal bone geometry at the metacarpal bone shaft of rheumatoid arthritis patients with maintained muscle–bone relationship
Eser, P., Aeberli, D., Widmer, J., Möller, B., & Villiger, P. M. (2010) · Arthritis Care & Research · doi:10.1002/acr.20394 · Cited by 16
Prévention et traitement de l’ostéoporose cortisonique
Roux, C., & Orcel, P. (2003) · La Revue de Médecine Interne · doi:10.1016/s0248-8663(03)00105-x · Cited by 16
Effect of Denosumab Compared With Risedronate on Bone Strength in Patients Initiating or Continuing Glucocorticoid Treatment
Geusens, P., Bevers, M. S. A. M., van Rietbergen, B., Messina, O. D., Lespessailles, É., Oliveri, B., Chapurlat, R. D., Engelke, K., Chines, A. A., Huang, S., et al. (2020) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.4551 · Cited by 15
Investigation of bone toxicity in drug development: review of current and emerging technologies
Tuladhar, A., Guffroy, M., Finnema, S. J., Christmann, R., Vleet, T. R. V., Mayana, S. A. K., & Fossey, S. L. (2025) · Toxicological Sciences · doi:10.1093/toxsci/kfaf131 · Cited by 15
Towards novel measurements of remodeling activity in cortical bone: implications for osteoporosis and related pharmaceutical treatments
Loundagin, L. L., & Cooper, D. (2022) · European Cells and Materials · doi:10.22203/ecm.v043a15 · Cited by 14
New insights into the biology of glucocorticoid-induced osteoporosis
Lane, N. E., & Yao, W. (2011) · IBMS BoneKEy · doi:10.1138/20110511 · Cited by 15
Abnormal microarchitecture and stiffness in postmenopausal women using chronic inhaled glucocorticoids
Liu, Y., DiMango, E., Bucovsky, M., Agarwal, S., Nishiyama, K. K., Guo, X.-D. E., Shane, E. J., & Stein, E. M. (2018) · Osteoporosis International · doi:10.1007/s00198-018-4591-9 · Cited by 13
Bone Mass, Microstructure, and Strength Can Discriminate Vertebral Fracture in Patients on Long-Term Steroid Treatment
Shen, J., Griffith, J. F., ZHU, T. Y., Tang, P., Kun, E. W. L., Lee, V. K. L., Yip, R. M.-L., Kwok, K. Y., Ying, S. K. Y., Ho, C. T. K., et al. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-00490 · Cited by 13
Effects of thalidomide on the development of bone damage caused by prednisolone in rats
Ilona, K.-S., Zych, M., Rotko, K., & Sedlak, L. (2012) · Pharmacological Reports · doi:10.1016/s1734-1140(12)70779-x · Cited by 15
Evaluation of bone-related mechanical properties in female patients with long-term remission of Cushing's syndrome using quantitative computed tomography–based finite element analysis
Giuliodori, A., Soudah, E., Malouf, J., Martel‐Duguech, L., Amodru, V., Gil, J., Hernández, J. A., Puig‐Domingo, M., Webb, S. M., & Valassi, E. (2024) · European Journal of Endocrinology · doi:10.1093/ejendo/lvae004 · Cited by 12
Corticosteroid-induced osteoporosis and fractures
Romas, E. (2008) · Australian Prescriber · doi:10.18773/austprescr.2008.026 · Cited by 13
Ostéoporose cortisonique
Orcel, P., & Roux, C. (2001) · Revue du Rhumatisme · doi:10.1016/s1169-8330(01)00181-8 · Cited by 12
Influence of bone marrow composition on measurements of trabecular microstructure using decay due to diffusion in the internal field MRI: Simulations and clinical studies
Sprinkhuizen, S. M., Ackerman, J. L., & Song, Y. (2013) · Magnetic Resonance in Medicine · doi:10.1002/mrm.25061 · Cited by 11
Coexistence of bone and vascular disturbances in patients with endogenous glucocorticoid excess
Yano, C., Yokomoto‐Umakoshi, M., Fujita, M., Umakoshi, H., Yano, S., Iwahashi, N., Katsuhara, S., Kaneko, H., Ogata, M., Fukumoto, T., et al. (2022) · Bone Reports · doi:10.1016/j.bonr.2022.101610 · Cited by 11
Piper Sarmentosum: A New Hope for the Treatment of Osteoporosis
Ramli, E. S. M., Suhaimi, F. H., Ahmad, F., Shuid, A. N., Mohamad, N., & Soelaiman, I. N. (2013) · Current Drug Targets · doi:10.2174/13894501113146660228 · Cited by 11
Growth hormone can reverse glucocorticoid-induced low bone turnover on cortical but not on cancellous bone surfaces in adult Wistar rats
Ørtoft, G., Andreassen, T. T., & Oxlund, H. (2004) · Bone · doi:10.1016/j.bone.2004.07.015 · Cited by 11
Glucocorticoid‐induced osteoporosis
Sambrook, P. N. (2008) · International Journal of Rheumatic Diseases · doi:10.1111/j.1756-185x.2008.00391.x · Cited by 11
Effects of methylprednisolone on bone mineral density and microarchitecture of trabecular bones in rats with administration time and assessed by micro-computed tomography
Liu, S. P., Liao, E. Y., Chen, J., Yang, S. M., Li, J. W., Sheng, Z., Mo, H., Wu, X., Yao, L., & Dai, R. C. (2008) · Acta Radiologica · doi:10.1080/02841850802613122 · Cited by 10
Ferulic acid attenuates osteoporosis induced by glucocorticoid through regulating the GSK-3β/Lrp-5/ERK signalling pathways
Zhou, W., Chen, B., Shang, J., & Li, R. (2021) · Physiology International · doi:10.1556/2060.2021.00180 · Cited by 10

Authors: Carbonare, L. D., Arlot, M. E., Chavassieux, P. M., Roux, J. P., Portero, N. R., & Meunier, P. J.
Affiliations: Inserm (FR)
Institut National de la Santé et de la Recherche Médicale Unit 403 and Laboratoire d'Histodynamique Osseuse, Lyon, France
Corresponding author: Carbonare, L. Dalle
ORCID: Carbonare, L. Dalle
Chavassieux, P. M.
Meunier, P. J.
Venue: Journal of Bone and Mineral Research
Publisher: Oxford University Press (OUP)
Published: 2001-01-01
Volume: 16
Issue: 1
Pages: 97-103
ISSN: 0884-0431 (ISSN-L)
1523-4681
DOI: 10.1359/jbmr.2001.16.1.97
OpenAlex: W1972567404
Cited by: 309
References: 40
Citations by year: 2026: 3 · 2025: 3 · 2024: 6 · 2023: 8 · 2022: 10 · 2021: 9 · 2020: 13 · 2019: 11 · 2018: 14 · 2017: 7 · 2016: 5 · 2015: 12 · 2014: 12 · 2013: 12 · 2012: 16
FWCI: 20.64
Type: journal article
Language: en
Open access: closed
Licence: academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model (vor)
Locations: Journal of Bone and Mineral Research (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Orthopedics and Sports Medicine › Bone health and osteoporosis research
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bone Metabolism and Diseases
Life Sciences › Biochemistry, Genetics and Molecular Biology › Endocrinology › Estrogen and related hormone effects
Keywords: glucocorticoid-induced osteoporosis, postmenopausal osteoporosis, trabecular bone microarchitecture, bone remodeling, trabecular bone, bone formation rate, bone resorption, cumulative glucocorticoid dose, bone loss, trabecular thickness, wall thickness, Euler characteristic
MeSH terms: Aged, Biopsy, Bone and Bones, Female, Glucocorticoids, Histocytochemistry, Humans, Ilium, Middle Aged, Osteoporosis, Osteoporosis, Postmenopausal, Bone Remodeling, Postmenopause

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Comparison of trabecular bone microarchitecture and remodeling in glucocorticoid-induced and postmenopausal osteoporosis.

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks